Campbell Rogers, the Chief Medical Officer of $HTFL, sold 65,153 shares of the company on 02-12-2026 for an estimated $1,595,486. We received data on the trade from a recent SEC filing. This was a sale of approximately 46.1% of their shares of this class of stock. Following this trade, they now own 76,034 shares of this class of $HTFL stock.
$HTFL Insider Trading Activity
$HTFL insiders have traded $HTFL stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $HTFL stock by insiders over the last 6 months:
- CAPITAL LIFE SCIENCES INVESTORS, LLC BAIN sold 2,000,000 shares for an estimated $56,100,000
- CAMPBELL ROGERS (Chief Medical Officer) sold 65,153 shares for an estimated $1,595,486
- JEFFREY C LIGHTCAP purchased 40,000 shares for an estimated $1,053,680
- JOHN C.M. FARQUHAR (Chief Executive Officer) sold 22,562 shares for an estimated $619,552
- JULIE A CULLIVAN sold 8,000 shares for an estimated $218,560
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HTFL Hedge Fund Activity
We have seen 92 institutional investors add shares of $HTFL stock to their portfolio, and 29 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC added 12,448,158 shares (+inf%) to their portfolio in Q3 2025, for an estimated $419,004,998
- WELLINGTON MANAGEMENT GROUP LLP added 4,880,064 shares (+inf%) to their portfolio in Q3 2025, for an estimated $164,262,954
- SCHUSTERMAN INTERESTS, LLC added 1,939,201 shares (+inf%) to their portfolio in Q3 2025, for an estimated $65,273,505
- CAPRICORN INVESTMENT GROUP LLC added 1,661,601 shares (+inf%) to their portfolio in Q4 2025, for an estimated $48,435,669
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,431,011 shares (+inf%) to their portfolio in Q4 2025, for an estimated $41,713,970
- CAPITAL INTERNATIONAL INVESTORS removed 1,297,423 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $37,819,880
- BAMCO INC /NY/ added 1,066,371 shares (+86.2%) to their portfolio in Q4 2025, for an estimated $31,084,714
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HTFL Analyst Ratings
Wall Street analysts have issued reports on $HTFL in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/28/2026
- JP Morgan issued a "Overweight" rating on 11/13/2025
- Canaccord Genuity issued a "Buy" rating on 11/13/2025
- Stifel issued a "Buy" rating on 11/13/2025
- Piper Sandler issued a "Overweight" rating on 09/02/2025
To track analyst ratings and price targets for $HTFL, check out Quiver Quantitative's $HTFL forecast page.
$HTFL Price Targets
Multiple analysts have issued price targets for $HTFL recently. We have seen 5 analysts offer price targets for $HTFL in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Larry Biegelsen from Wells Fargo set a target price of $38.0 on 01/28/2026
- Robbie Marcus from JP Morgan set a target price of $40.0 on 11/13/2025
- William Plovanic from Canaccord Genuity set a target price of $40.0 on 11/13/2025
- Rick Wise from Stifel set a target price of $40.0 on 11/13/2025
- Matt OBrien from Piper Sandler set a target price of $38.0 on 09/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
